文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

M2e偶联金纳米颗粒流感疫苗在高温下热稳定并保护雪貂

M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
PubMed 文献 · Vaccine · 2021-07-21

该研究评估M2e偶联金纳米颗粒流感疫苗的热稳定性及保护效果。冻干疫苗在4°C和37°C存放3个月、50°C存放2周后仍可无聚集复溶,小鼠鼻内接种诱导相似IgG并完全抵抗致死性流感攻击;雪貂接种诱导M2e特异性IgG,鼻内免疫组鼻洗液病毒水平降低。

要点

  • 冻干M2e-AuNP疫苗在4°C和37°C存放3个月、50°C存放2周后仍可无聚集复溶。
  • 复溶疫苗鼻内接种小鼠诱导M2e特异性IgG及亚型,完全保护致死性流感攻击。
  • 雪貂鼻内或肌内接种诱导M2e特异性IgG,鼻内组鼻洗液病毒水平降低。

核心结论

  • M2e偶联金纳米颗粒流感疫苗以冻干形式在高温下热稳定,复溶后在小鼠中保持免疫原性和完全保护。
  • 雪貂接种后诱导M2e特异性IgG,鼻内免疫可降低鼻洗液病毒水平。

研究设计与样本

  • 研究为实验性疫苗研究,评估冻干M2e-AuNP疫苗的热稳定性、复溶后免疫原性及保护效果。
  • 稳定性测试条件:4°C存放3个月、37°C存放3个月、50°C存放2周。
  • 动物实验:小鼠鼻内接种复溶疫苗,雪貂鼻内或肌内接种疫苗。

主要发现

  • 冻干疫苗在4°C和37°C存放3个月、50°C存放2周后可无聚集复溶于水。
  • 复溶疫苗鼻内接种小鼠诱导的M2e特异性IgG及IgG亚型与新鲜配制疫苗相似。
  • 复溶疫苗鼻内接种小鼠完全保护致死性流感A攻击。
  • 雪貂鼻内或肌内接种诱导M2e特异性IgG,鼻内免疫组鼻洗液病毒水平降低。

关键数值与推荐

  • 热稳定性条件:4°C 3个月、37°C 3个月、50°C 2周(冻干形式)。
  • 小鼠鼻内接种复溶疫苗后血清M2e特异性IgG及亚型与新鲜疫苗相似。
  • 小鼠鼻内接种复溶疫苗后完全保护致死性流感A攻击。
  • 雪貂鼻内或肌内接种后诱导M2e特异性IgG,鼻内组鼻洗液病毒水平降低。

临床怎么用

  • 热稳定疫苗可减少对冷藏系统的依赖,降低经济负担。
  • 允许运输至冷藏条件匮乏的偏远地区,扩大疫苗接种覆盖。
  • 鼻内接种可能诱导黏膜免疫并降低病毒排出,但需进一步临床验证。

局限性

  • 研究仅在小鼠和雪貂中进行,尚未在人体验证。
  • 原文未报告疫苗在人体中的热稳定性、免疫原性和保护效果数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Currently approved influenza vaccines are not only limited in breadth of protection but also have a limited shelf-life of 12-18 months when stored under appropriate conditions (2-8 °C). Inadvertent alteration in storage temperatures during manufacturing, transportation, distribution until delivery to patient, can damage the vaccine thus reducing its efficacy. A thermally stable vaccine can decrease the economic burden by reducing reliance on refrigeration system and can also enhance outreach of the vaccination program by allowing transportation to remote areas of the world where refrigerated conditions are scarce. We have previously developed a broadly protective influenza A vaccine by coupling the highly conserved extracellular region of the matrix 2 protein (M2e) of influenza A virus to gold nanoparticles (AuNPs) and upon subsequent addition of toll-like receptor 9 agonist - CpG, as an adjuvant, have shown its breadth of protection in a mouse model. In this study, we show that the vaccine is thermally stable when stored at 4 °C for 3 months, 37 °C for 3 months and 50 °C for 2 weeks in its lyophilized form, and later it was possible to readily reconstitute it in water without aggregation. Intranasal vaccination of mice using reconstituted vaccine induced M2e-specific IgG and IgG subtypes in serum similar to the freshly formulated vaccine, and fully protected mice against lethal influenza A challenge. Immunization of ferrets intranasally or intramuscularly with the vaccine induced M2e-specific IgG and there was reduced virus level in nasal wash of ferrets immunized through intranasal route.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ingrole RSJ, Tao W, Joshi G, et al. M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets. Vaccine. 2021. PMID: 34301431. doi:10.1016/j.vaccine.2021.07.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。